Caregiver psychosocial characteristics and children's adherence to antiretroviral therapy

AIDS Patient Care and STDs

Volumn 20, Issue 6, 2006, Pages 429-437

  Marhefka, Stephanie L ^a   Tepper, Vicki J ^b   Brown, Jennifer L ^b   Farley, John J ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BRIEF SYMPTOM INVENTORY; CAREGIVER; CHILD; DEMOGRAPHY; DISTRESS SYNDROME; FAMILY SUPPORT SCALE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PARENTING STRESS INDEX; PATIENT COMPLIANCE; PSYCHOMETRY; SOCIAL PSYCHOLOGY; STRESS; SUPPORT FUNCTIONS SCALE; TREATMENT DURATION; URBAN AREA;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAREGIVERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGY;

EID: 33745611173     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.429     Document Type: Article

References (48)

1. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-366.
2. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis 2001;33:700-705.
3. de Martino M, de Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA 2001;284:190-197.
4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
5. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
6. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics 2002;109:e61.
7. Fatkenhauer G, Theisen A, Rockstroh J. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS 1997;11:F11-F116.
8. Bachanas PJ, Kullgren KA, Schwartz KS, et al. Psychological adjustment in caregivers of school-age children infected with HIV: Stress, coping, and family factors. J Pediatr Psychol 2001;26:331-342.
9. Brown LK, Lourie KJ, Pao M. Children and adolescents living with HIV and AIDS: A review. J Child Psychol Psychiatry 2000;41:81-96.
10. Mellins CA, Ehrhardt AA. Families affected by pediatric acquired immunodeficiency syndrome: Sources of stress and coping. J Dev Behav Pediatr 1994;15: S54-60.
11. Brownbridge G, Fielding DM. Psychosocial adjustment and adherence to daily treatments regimens. Pediatri Nephr 1994;8:744-749.
12. Demas PA, Webber MP, Schoenbaum EE, et al. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: A preliminary study. Pediatrics 2002;110:e35.
13. Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Healthcare 1998;12:196-202.
14. Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J 2003;22:56-62.
15. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J 2000;19:1148-1153.
16. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: Examination of the role of caregiver health beliefs. AIDS Care 2001;13:617-629.
17. Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004;23:1035-1041.
18. Bartlett SJ, Krishnan JA, Riekert KA, Butz AM, Malveaux FJ, Rand CS. Maternal depressive symptoms and adherence to therapy in inner-city children with asthma. Pediatrics 2004;113:229-237.
19. DiMatteo MR. Social support and patient adherence to medical treatment: A meta-analysis. Health Psychol 2004;23:207-218.
20. Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immun Defic Syndr 2003;33:211-218.
21. Katko E, Johnson GM, Fowler SL, Turner RB. Assessment of adherence with medications in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2001;20:1174-1176.
22. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1999;18:682-689.
23. Abidin RR. Parenting Stress Index, Professional Manual, 3rd ed. Odessa, Florida: Psychological Assessment Resources, 1995.
24. Derogatis LR. BSI: Brief Symptom Inventory. Administration, Scoring, and Procedures Manual, 4th ed. Minneapolis, MN: NCS Pearson, Inc., 1993.
25. Dunst CJ, Jenkins V, Trivette CM. The Family Support Scale (FSS). In: Dunst CJTC, Deal AG, eds. Enabling and Empowering Families: Principles and Guidelines for Practice. Cambridge, MA: Brookline Books, 1988.
26. Dunst CJ, Trivette CM. The Support Functions Scale (SFS). In: Dunst CJTC, Deal AG, ed. Enabling and Empowering Families: Principles and Guidelines for Practice. Cambridge, MA: Brookline Books; 1988.
27. Mofenson LM KJ, Meyer WA 3rd, Bethel J, Rich K, Pahwa S, et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. J Infect Dis 1997;175:1029-1038.
28. Patterson JM. Critical factors affecting family compliance with home treatment for children with cystic fibrosis. Family Relat 1985;34:79-89.
29. Mellins CA, Brackis-Cott E, Dolezal C, Richards A, Nicholas SW, Abrams EJ. Patterns of status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psychiatry 2002;7:101-114.
30. Brackis-Cott E, Mellins CA, Abrams E, Reval T, Dolezal C. Pediatric HIV medication adherence: The views of medical providers from two primary care programs. J Pediatr Healthcare 2003;17:252-260.
31. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999;13:1763-1769.
32. Singh N, Berman SM, Swindell S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-830.
33. Mellins CA, Kang E, Leu CS, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care STDs 2003;17:407-416.
34. Gonzalez JS, Penedo PJ, Antoni MH, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol 2004;23:413-418.
35. Harzke AJ, Williams ML, Nilsson-Schonnesson L, Ross MW, Timpson S, Keel KB. Psychosocial factors associated with adherence to antiretroviral medications in a sample of HIV-positive African American drug users. AIDS Care 2004;16:458-470.
36. Murphy DA, Marelich WD, Hoffman D, Steers WN. Predictors of antiretroviral adherence. AIDS Care 2004;16:471-484.
37. Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychol 2004;23:363-370.
38. Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDs 2002;16:599-608.
39. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30(Suppl 2):S171-176.
40. Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immun Defic Syndr 2002;31(Suppl 3):S149-153.
41. Kleeberger CA, Buechner J, Palella F, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS 2004;18:683-688.
42. Mocroft A, Madge S, Johnson AM, et al. A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immun Defic Syndr 1999;22:369-378.
43. Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care STDs 2000;14:351-358.
44. Broers B, Morabia A, Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med 1994;154:1121-1127.
45. Quittner AL, Espelage DL, Levers-Landis C, Drotar D. Measuring adherence to medical treatments in childhood chronic illness: Considering multiple methods and sources of information. J Clin Psychol Med Settings 2000;7:41-53.
46. Hill Z, Kendall C, Fernandez M. Patterns of adherence to antiretrovirals: why adherence has no simple measure. AIDS Patient Care STDs 2003;17:519-525.
47. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: A review of current literature and ongoing studies. Top HIV Med 2003;11:185-198.
48. Berrien VM, Salazar JC, Reynolds E, McKay K. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDs 2004;18:355-363.